Search Within

Mary G Boyle

Formats
  1. Journal Article (22)
  2. Meeting Abstract (7)
Groups
  1. Nursing (29)
  2. Department of Medicine (17)
  3. Genitourinary Oncology Service (17)
  4. Solid Tumor Oncology Division (17)
  5. Surgery (9)
  6. Urology (9)

More Groups

People
  1. Dean Bajorin (17)
  2. Dominique Srdanovic (10)
  3. Harry Herr (8)
  4. Alexia Iasonos (7)
  5. Matthew Milowsky (7)
  6. Jamie Riches (6)

More People

Years
  1. 2010 (1)
  2. 2009 (2)
  3. 2008 (2)
  4. 2007 (6)
  5. 2006 (2)
  6. 2005 (2)

More Years

Publications
  1. Journal of Clinical Oncology (8)
  2. Cancer (3)
  3. Annals of Oncology (2)
  4. Oncology Nursing Forum (2)
  5. Cancer Investigation (1)
  6. EJC Supplements (1)

More Publications

Publishers
  1. Gannett Healthcare Group (10)
  2. American Society of Clinical Oncology (8)
  3. Wiley Blackwell (3)
  4. Oncology Nursing Society (ONS) (2)
  5. Oxford University Press (2)
  6. Elsevier Science, Inc. (1)

More Publishers

Results (29)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CE 343: Bladder cancer
    Journal Article

    Depalma, D.; Boyle, M. G.
    Nursing Spectrum (Greater New York/New Jersey Metro) (2004)

    Fulltext@MSK | Save
  • CE 343: Bladder cancer
    Journal Article

    Depalma, D.; Boyle, M. G.
    Nursing Spectrum (Washington DC/Baltimore Metro) (2004)

    Fulltext@MSK | Save
  • CE 343: Bladder cancer
    Journal Article

    Depalma, D.; Boyle, M. G.
    NurseWeek (Heartland) (2004)

    Fulltext@MSK | Save
  • CE 343: Bladder cancer
    Journal Article

    Depalma, D.; Boyle, M. G.
    NurseWeek (Mountain West) (2004)

    Fulltext@MSK | Save
  • CE 343: Bladder cancer
    Journal Article

    Depalma, D.; Boyle, M. G.
    Nursing Spectrum (Greater Philadelphia/Tri-State) (2004)

    Fulltext@MSK | Save
  • Phase I evaluation of sequential doxorubicin + gemcitabine then ifosfamide + paclitaxel + cisplatin for patients with unresectable or metastatic transitional-cell carcinoma of the urothelial tract
    Journal Article

    Dodd, P. M.; Mccaffrey, J. A.; Hilton, S.; Mazumdar, M.; Herr, H.; Kelly, W. K.; Icasiano, E.; Boyle, M. G.; Bajorin, D. F.
    Journal of Clinical Oncology (2000)

    Fulltext@MSK | Save
  • Evaluation of drug delivery and survival impact of dose-intense relative to conventional-dose methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy in urothelial cancer
    Journal Article

    Dodd, P. M.; Mccaffrey, J. A.; Mazumdar, M.; Scher, H.; Higgins, G.; Boyle, M. G.; Herr, H.; Bajorin, D. F.
    Cancer Investigation (2000)

    Fulltext@MSK | Save
  • Long-term survival in metastatic transitional-cell carcinoma and prognostic factors predicting outcome of therapy
    Journal Article

    Bajorin, D. F.; Dodd, P. M.; Mazumdar, M.; Fazzari, M.; McCaffrey, J. A.; Scher, H. I.; Herr, H.; Higgins, G.; Boyle, M. G.
    Journal of Clinical Oncology (1999)

    Fulltext@MSK | Save
  • Outcome of postchemotherapy surgery after treatment with methotrexate, vinblastine, doxorubicin, and cisplatin in patients with unresectable or metastatic transitional cell carcinoma
    Journal Article

    Dodd, P. M.; McCaffrey, J. A.; Herr, H.; Mazumdar, M.; Bacik, J.; Higgins, G.; Boyle, M. G.; Scher, H. I.; Bajorin, D. F.
    Journal of Clinical Oncology (1999)

    Fulltext@MSK | Save